We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+0.09%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$15.4B
AUM Growth
-$4.25B
(-22%)
Cap. Flow
-$11.2B
Cap. Flow
% of AUM
-72.83%
Top 10 Holdings %
Top 10 Hldgs %
18.29%
Holding
643
New
38
Increased
264
Reduced
90
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$129M |
| 2 |
American International
AIG
|
+$82.2M |
| 3 |
AGN
Allergan plc
AGN
|
+$80.4M |
| 4 |
Meta Platforms (Facebook)
META
|
+$74.9M |
| 5 |
Humana
HUM
|
+$67.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$92.5M |
| 2 |
Wells Fargo
WFC
|
+$55.4M |
| 3 |
AMT.PRB
American Tower Corporation
AMT.PRB
|
+$50.1M |
| 4 |
Apple
AAPL
|
+$48.6M |
| 5 |
ZEN
ZENDESK INC
ZEN
|
+$36.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.23% |
| 2 | Technology | 9.26% |
| 3 | Healthcare | 8.87% |
| 4 | Communication Services | 6.39% |
| 5 | Consumer Discretionary | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Philip Morris
PM
$301B
| $82.3M | 0.54% |
828,098
+71,298
| +9% | +$7.43M |
|
27
DuPont de Nemours
DD
$18.6B
| $81.9M | 0.53% |
507,833
+2,515
| +0.5% | +$455K |
|
28
McDonald's
MCD
$188B
| $80M | 0.52% |
511,438
+225,576
| +79% | +$37.1M |
|
29
Comcast
CMCSA
$79.1B
| $78.7M | 0.51% |
2,302,727
+14,504
| +0.6% | +$563K |
|
|
ANTX
30
DELISTED
Anthem, Inc.
ANTX
| $77.5M | 0.5% |
1,444,675
-145,880
| -9% | -$8.37M |
|
|
NEE.PRR
31
DELISTED
NextEra Energy, Inc.
NEE.PRR
| $77.3M | 0.5% |
1,340,113
+538,666
| +67% | +$30.1M |
|
|
ETFC
32
DELISTED
E*Trade Financial Corporation
ETFC
| $76.4M | 0.5% |
1,379,580
-252,638
| -15% | -$13.5M |
|
33
Coca-Cola
KO
$354B
| $74.9M | 0.49% |
1,725,485
+19,749
| +1% | +$887K |
|
34
Citigroup
C
$222B
| $74.4M | 0.48% |
1,101,941
-255,218
| -19% | -$19.2M |
|
35
Mastercard
MA
$477B
| $74.2M | 0.48% |
423,353
+42,986
| +11% | +$7.35M |
|
36
SLB Ltd
SLB
$77.8B
| $71.8M | 0.47% |
1,108,192
+109,241
| +11% | +$7.63M |
|
37
Goldman Sachs
GS
$313B
| $71.7M | 0.47% |
284,490
+66,756
| +31% | +$17.4M |
|
38
Pfizer
PFE
$140B
| $71.5M | 0.47% |
2,122,627
+31,197
| +1% | +$1.07M |
|
39
Procter & Gamble
PG
$343B
| $69.4M | 0.45% |
875,516
+3,236
| +0.4% | +$270K |
|
|
40
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
| $68.6M | 0.45% |
53,155
+4,499
| +9% | +$5.77M |
|
|
41
Humana
HUM
$46.7B
| $67.1M | 0.44% |
+249,674
| New | +$67.6M |
|
42
Netflix
NFLX
$292B
| $66.5M | 0.43% |
2,252,100
-1,212,760
| -35% | -$33M |
|
|
ALXN
43
DELISTED
Alexion Pharmaceuticals
ALXN
| $66.4M | 0.43% |
595,578
+113,946
| +24% | +$13.6M |
|
44
Booking.com
BKNG
$138B
| $63.9M | 0.42% |
767,775
+148,775
| +24% | +$11.7M |
|
45
AT&T
T
$165B
| $61.6M | 0.4% |
2,287,279
+39,698
| +2% | +$1.1M |
|
46
PepsiCo
PEP
$186B
| $61.2M | 0.4% |
560,313
+7,565
| +1% | +$860K |
|
47
Intercontinental Exchange
ICE
$82.4B
| $61.1M | 0.4% |
842,574
+54,441
| +7% | +$3.98M |
|
|
BDXA
48
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
| $61M | 0.4% |
1,044,814
-1,825
| -0.2% | -$108K |
|
49
Applied Materials
AMAT
$426B
| $60.5M | 0.39% |
1,087,641
-5,131
| -0.5% | -$286K |
|
50
Starbucks
SBUX
$118B
| $59.7M | 0.39% |
1,031,079
-275,205
| -21% | -$15.9M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, Calamos Advisors held 643 positions worth $15.4B, down 22% from $19.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Calamos Advisors withdrew a net $11.2B in Q1 2018, closing 44 positions and reducing 90 holdings. Its most notable exit was Allergan plc, an estimated $92.5M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 8.5% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Calamos Advisors opened a new position in Humana worth $67.1M.
- Calamos Advisors's largest Q1 2018 buy was Humana: 249,674 shares worth $67.1M.
- Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $129M increase.
- Calamos Advisors's biggest Q1 2018 reduction was Wells Fargo, cutting an estimated $55.4M.
- Calamos Advisors fully exited Allergan plc in Q1 2018, selling an estimated $92.5M.
- Calamos Advisors's ten largest holdings make up 18% of its $15.4B portfolio in Q1 2018.
- Calamos Advisors opened 38 new positions and closed 44 in Q1 2018.
- Calamos Advisors's portfolio value fell 22% quarter-over-quarter to $15.4B.
Based on Calamos Advisors's 13F filing for Q1 2018, filed 13 Apr 2018.